THEME: "Emerging Trends in Heart and Cardiology Research"
Harvard University, USA
Title: Plasma total and individual non-esterified fatty acids and risk of heart failure
.
Background:
Although high plasma concentration of
non-esterified fatty acids (NEFAs) have been associated with lipotoxicity,
glucose dysregulation, and incidence of type 2 diabetes, little is known about
the role of total as well as individual NEFAs on the incidence of heart failure
(HF)
Hypotheses:
We tested the hypotheses that (1)
plasma concentration of total NEFAs is positively associated with the incidence of
HF and (2) only few individual NEFAs confer elevated risk of HF.
Methods:
We prospectively analyzed data from
the Cardiovascular Health Study. Total NEFAs (n=4,248) were measured by the
Wako enzymatic method and individual NEFAs were measured by gas chromatography
(n=2,140). HF events were adjudicated by the Events Committee.
Results:
The mean age at baseline (1992–93)
was 75 years. During a median follow up of 11 years, 1,286 (30%) participants
developed HF. In a multivariable adjusted Cox regression, each standard
deviation higher plasma NEFAs was associated with 13% (95% CI: 6% to 19%)
higher risk of HF (p <0.001). Analysis of 35 individual NEFAs showed inverse
associations [HR (95% CI) per standard deviation] of non-esterified
pentadecanoic [0.73 (0.57-0.94)], ?-linolenic acid (GLA) [0.87 (0.75-1.00)],
and docosahexaenoic acid (DHA) [0.73 (0.61-0.88)] acids with HF, and positive
associations of non-esterified stearic [1.30 (1.04-1.63)] and nervonic [1.17
(1.06-1.29)] acids with HF.
Conclusion:
Among older adults, we observed a
positive association of plasma total NEFAs with HF that is driven by
non-esterified stearic acid and nervonic acid while inverse associations were
seen with plasma pentadecanoic, GLA, and DHA.